Cargando…

Correction: MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549290/ https://www.ncbi.nlm.nih.gov/pubmed/26305556 http://dx.doi.org/10.1371/journal.pone.0137155

Ejemplares similares

MicroRNA-330-5p as a Putative Modulator of Neoadjuvant Chemoradiotherapy Sensitivity in Oesophageal Adenocarcinoma
por: Bibby, Becky A. S., et al.
Publicado: (2015)

Silencing microRNA-330-5p increases MMP1 expression and promotes an invasive phenotype in oesophageal adenocarcinoma
por: Bibby, Becky A. S., et al.
Publicado: (2019)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Correction to: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway
por: Wei, Chun-Hua, et al.
Publicado: (2018)

Correction for: Integrative analysis of exosomal microRNA-149-5p in lung adenocarcinoma
por: Tian, Wen, et al.
Publicado: (2022)

Conditional survival after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: Hagens, E. R. C., et al.
Publicado: (2020)

The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells
por: Valkema, Maria J, et al.
Publicado: (2023)

Hedgehog signal activation in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy
por: Yoshikawa, R, et al.
Publicado: (2008)

Diagnostic performance of MRI for assessment of response to neoadjuvant chemoradiotherapy in oesophageal cancer
por: Vollenbrock, S. E., et al.
Publicado: (2019)

Predicting Response to Neoadjuvant Therapy in Oesophageal Adenocarcinoma
por: Jiang, William, et al.
Publicado: (2022)

Expression signatures and roles of MicroRNAs in human oesophageal adenocarcinomas
por: Kong, Xiangyi, et al.
Publicado: (2017)

Correction: Molecular predictors of brain metastasis-related microRNAs in lung adenocarcinoma
por: Sun, Guogui, et al.
Publicado: (2020)

Active surveillance of oesophageal cancer after response to neoadjuvant chemoradiotherapy: dysphagia is uncommon
por: Valkema, Maria J, et al.
Publicado: (2023)

Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus
por: Slotta-Huspenina, Julia, et al.
Publicado: (2018)

Correction: Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Publicado: (2020)

Molecular profiles of response to neoadjuvant chemoradiotherapy in oesophageal cancers to develop personalized treatment strategies
por: de Klerk, Leonie K., et al.
Publicado: (2021)

Correction to: miR-330-5p targets SPRY2 to promote hepatocellular carcinoma progression via MAPK/ERK signaling
por: Xiao, Shuai, et al.
Publicado: (2021)

Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network
por: Zhu, Yaqun, et al.
Publicado: (2016)

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by radical surgery for locally advanced oesophageal squamous cell carcinoma: meta-analysis
por: Kamarajah, Sivesh K, et al.
Publicado: (2022)

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer
por: Yoon, Han Gyul, et al.
Publicado: (2021)

Detection of circulating tumour DNA after neoadjuvant chemoradiotherapy in patients with locally advanced oesophageal cancer
por: Eyck, Ben M, et al.
Publicado: (2022)

Author response to: Neoadjuvant chemoradiotherapy or chemotherapy alone for oesophageal cancer: population-based cohort study
por: Kamarajah, S K, et al.
Publicado: (2021)

Mutant p53 Mediates Sensitivity to Cancer Treatment Agents in Oesophageal Adenocarcinoma Associated with MicroRNA and SLC7A11 Expression
por: Eichelmann, Ann-Kathrin, et al.
Publicado: (2021)

Correction: Human MicroRNA Targets
por: John, Bino, et al.
Publicado: (2005)

Author Correction: Authentication and characterisation of a new oesophageal adenocarcinoma cell line: MFD-1
por: Garcia, Edwin, et al.
Publicado: (2019)

Prognostic implications of the extent of downstaging after neoadjuvant therapy for oesophageal adenocarcinoma and oesophageal squamous cell carcinoma
por: Kamarajah, Sivesh K, et al.
Publicado: (2023)

Correction: A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas
por: Adams, Olivia, et al.
Publicado: (2019)

Correction: The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy
por: Cui, Jian, et al.
Publicado: (2019)

Circulating microRNAs as potential biomarkers to detect transformation of Barrett’s oesophagus to oesophageal adenocarcinoma
por: Matsuzaki, Juntaro, et al.
Publicado: (2017)

Publisher Correction: Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancer
por: Wang, Hongmiao, et al.
Publicado: (2023)

Correction: Gupta, P.M.; et al. Iron, Anemia, and Iron Deficiency Anemia among Young Children in the United States Nutrients 2016, 8, 330
por: Gupta, Priya M., et al.
Publicado: (2017)

MicroRNA-330-5p inhibits osteosarcoma cell growth and invasion by targeting the proto-oncogene survivin
por: Wang, Hao, et al.
Publicado: (2019)

Upregulated microRNA-330-3p promotes calcification in the bicuspid aortic valve via targeting CREBBP
por: Zheng, Rui, et al.
Publicado: (2020)

MicroRNA miR-330-3p suppresses the progression of ovarian cancer by targeting RIPK4
por: Cai, Li, et al.
Publicado: (2021)

Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer
por: de Jongh, M, et al.
Publicado: (2021)

Correction to: CIRSE Standards of Practice on Oesophageal and Gastroduodenal Stenting
por: Diamantopoulos, Athanasios, et al.
Publicado: (2023)

An Evaluation of Neoadjuvant Chemoradiotherapy for Patients with Resectable Pancreatic Ductal Adenocarcinoma
por: Jiang, Hui, et al.
Publicado: (2013)

MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
por: Svoboda, Marek, et al.
Publicado: (2012)

Correction: MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer
por: Kim, Tae Won, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cht43bhu8ckkrfviefp1he9rbf